Showing results (301-310 of 325) with videos related to
Sort By:
Pageof 33
The American Journal of Cardiology|December 22, 1999
Usefulness of intravenous enoxaparin for percutaneous coronary intervention in stable angina pectorisM M Rabah, J Premmereur, M Graham, et al.International Angiology : a Journal of the International Union of Angiology|November 1, 2008
Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfateM Clark, D Hoppensteadt, J Walenga, et al.Psychotherapy and Psychosomatics|January 1, 1989
Hostile personality characteristics and prostaglandins in essential hypertensionS Aritzi, J Demakis, G Demakis, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 24, 2001
Plasma tissue factor pathway inhibitor levels as a marker for postoperative bleeding after enoxaparin use in deep vein thrombosis prophylaxis in orthopedics and general surgeryS I Hakki, J Fareed, D A Hoppensteadt, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 4, 2007
Plasma thrombin activatable fibrinolysis inhibitor and tissue factor pathway inhibitor changes following sepsisThyyar M Ravindranath, Masakatsu Goto, Omer Iqbal, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 9, 2001
Anticoagulant and antiprotease profiles of a novel natural heparinomimetic mannopentaose phosphate sulfate (PI-88)M Demir, O Iqbal, D A Hoppensteadt, et al.International Angiology : a Journal of the International Union of Angiology|November 12, 2013
Association between serum levels of pro-metalloproteinase 1, tissue inhibitor of metalloproteinases 1 and 2 and prevalent cardiovascular disease in a population-based studyA G Panayiotou, E Kamilari, M Griffin, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 13, 2000
Plasma tissue factor pathway inhibitor levels as a marker for postoperative bleeding after enoxaparin use in deep vein thrombosis prophylaxis in orthopedics and general surgeryS I Hakki, J Fareed, D A Hoppensteadt, et al.Journal of Thrombosis and Thrombolysis|June 15, 2001
The hemostatic effects of warfarin titration in post CABG patients in comparison to placebo treatmentJ M Walenga, D Hoppensteadt, R Pifarré, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopeniaM A Rosenthal, D Rischin, G McArthur, et al.Pageof 33